Crossref
Tyrosine kinase inhibitors in differentiated thyroid carcinoma: a review of the clinical evidence
Clinical Investigation · 2011
DOI: 10.4155/cli.10.29 ↗At a glance
Journal article in Clinical Investigation, 2011. Written by Hendrieke C Hoftijzer and 6 co-authors. Cited 3 times so far (Crossref); 126 references.
Abstract (original language)
Inget abstract tillgängligt.
Cite
APA
Hoftijzer, H. C., Kapiteijn, E., Schneider, T., Hovens, G. C., Morreau, H., Gelderblom, H., & Smit, J. W. (2011). Tyrosine kinase inhibitors in differentiated thyroid carcinoma: a review of the clinical evidence. Clinical Investigation. https://doi.org/10.4155/cli.10.29
Vancouver
Hoftijzer HC, Kapiteijn E, Schneider T, Hovens GC, Morreau H, Gelderblom H, et al. Tyrosine kinase inhibitors in differentiated thyroid carcinoma: a review of the clinical evidence. Clinical Investigation. 2011. doi:10.4155/cli.10.29
BibTeX
@article{Hoftijzer2011,
author = {Hoftijzer, Hendrieke C and Kapiteijn, Ellen and Schneider, Tatiana and Hovens, Guido C and Morreau, Hans and Gelderblom, Hans and Smit, Johannes WA},
title = {Tyrosine kinase inhibitors in differentiated thyroid carcinoma: a review of the clinical evidence},
journal = {Clinical Investigation},
year = {2011},
doi = {10.4155/cli.10.29}
}
EUVIMED